Transplantation for hepatocellular carcinoma

Naoki Kawagishi

Research output: Chapter in Book/Report/Conference proceedingChapter


Liver transplantation (LT) is universally accepted as the final rescue therapy for endstage liver disease. Although there are a lot of primary diseases for the indication of LT, hepatocellular carcinoma (HCC) is one of the major indications of LT. In this chapter, LT is described on the basis of two different backgrounds i.e. Japan and western countries, and this contrast represents the living donor and the deceased donor transplantation. Milan criteria has been the gold standard criteria for HCC, but expanding the criteria has been proposed by some authors in light of favorable results noted in single center studies with variable durations of follow-up. The question still remains whether resection and LT should be considered as alternative, complimentary, or sequential in an intention-to-treat strategy. Immunosuppressants and chemotherapies on LT still remain controversial. The future direction of determining optimal LT for an individual patient requires consideration of numerous factors including liver damage, tumor stage, biomarkers, imaging techniques, and geographical transplant availability.

Original languageEnglish
Title of host publicationTherapy for Hepatocellular Carcinoma
Subtitle of host publicationEtiology and Treatment
PublisherNova Science Publishers, Inc.
Number of pages31
ISBN (Electronic)9781631175091
ISBN (Print)9781631179297
Publication statusPublished - 2014 Jan 1

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Transplantation for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this